Rafael Rivas-Chacon

TL;DR: Children with mild to moderate juvenile rheumatoid arthritis who were massaged by their parents 15 minutes a day for 30 days saw their pain decrease on self-reports, parent reports, and their physician's assessment of pain (both the incidence and severity) and pain-limiting activities.

TL;DR: Evidence that JDM affects young children is provided and the symptoms of the typical rash and weakness often follow a history of respiratory or gastrointestinal complaints, suggesting that the response to an infectious process may be implicated in JDM disease pathogenesis.

TL;DR: The IRG-S expands the diagnostic armamentarium in evaluating USAIDs and points to different pathways regulating IRG expression as well as 3 additional autoinflammatory diseases: IL-18-mediated PAP and recurrent MAS, NEMO∆5-associated autoinflammatory syndrome (NEMO-NDAS), and SAMD9L- associated autoinflammatory disease (SAMD 9L-SAAD).

TL;DR: In this paper, the impact of duration of untreated symptoms in children with juvenile dermatomyositis (JDM) on clinical and laboratory status at diagnosis was evaluated. But the authors focused on the first visit of 166 untreated children with JDM.

TL;DR: Rilonacept was found to maintain inflammatory remission in DIRA patients and was well tolerated and correlated with increased quality of life, most likely related to the lack of daily injections.